In the present study, we found that CREB knock down did not alleviate the inhibitory effect of cAMP on doxorubicin-induced p53 accumulation, and therefore CREB is dispensable for cAMP-induced destabilization of p53 in BCP-ALL cells. The gene discussed is CREB1; the disease is acute lymphoblastic leukemia.